daniel finkelstein, m.d., m.a. curriculum vitae · daniel finkelstein, m.d., m.a. 3 macula society,...

Daniel Finkelstein, M.D., M.A.

CURRICULUM VITAE

______________________________ June 21, 2017 Daniel Finkelstein, M.D., M.A.

1

DEMOGRAPHIC AND PERSONAL INFORMATION

Current Appointments

Andreas C. Dracopoulos Professorship

Professor of Ophthalmology

Wilmer Ophthalmological Institute

Johns Hopkins University, School of Medicine

Core Faculty Member

Berman Institute of Bioethics

Johns Hopkins University

PERSONAL DATA

OFFICE: The Wilmer Institute

The Johns Hopkins Hospital

600 N. Wolfe Street

Room 729 Maumenee Building

Baltimore, MD 21287-9227

Phone: (443) 287-8348

Cell: (410) 375-3756

FAX: (443) 769-1209

E-mail: [email protected]

HOME: 1907 South Road, Baltimore, MD 21209

EDUCATION AND TRAINING

Undergraduate: 1962 Harvard College

Graduate: 1967 University of PA Medical

Post-Sophomore

Fellowship: 1965 Free University of Berlin Electrophysiology

Internship: 1968 Pennsylvania Hospital, Philadelphia

Military: 1968-70 National Eye Institute

Staff Associate

Public Health Service

Residency: 1970-73 The Wilmer Institute Ophthalmology

1974-75 Chief Resident, The Wilmer Institute

mailto:[email protected]


2

Fellowship: 1973-74 The Wilmer Institute Retina

Experimental Retinal Neovascularization

Postgraduate 2008 St. Mary’s Seminary M.A. (Theology)

& University

Licensure: State of Maryland

Diplomat, National Board of Medicine Examiners

Board Certified, Ophthalmology

Research Interests: Retinal Vascular Disease

Retinal Degenerative Disease

Medical Ethics

National Positions:

Editorial Board, American Academy of Ophthalmology

“Focal Points” series 1988-1993

Editorial Board, Retina, 1980-1990

Editorial Board, Current Eye Research, 1993-1996

Deputy Chairman, Nationwide Collaborative

Central Vein Occlusion Study, 1987-1994

Chairman, Executive Committee, National Collaborative

Branch Vein Occlusion Randomized Clinical Trial, 1976-1986

Chairman, ARVO, Retina Section, 1981

Consultant, National Diabetes Advisory Board

Ocular Complication, October, 1979

Study Section, NIH, 1981-1984

Chairman, NIH Study Section, Visual Disorders, 1984

Co-Chairman, NIH Diabetes Coordinating Committee

Task Force on Animal Models, Ocular Complications

Chairman, Data and Safety Monitoring Board

Krypton-Argon Regression of Neovascularization

Multi-Center Randomized Clinical Trial, 1987

Director, Skills Transfer Course, Vein Occlusion

American Academy of Ophthalmology, 1992-1997

Macula Society, Program Chairman, 1987-1990

Macula Society, Credentials Chairman, 1995-1998

Macula Society, Treasurer, 1998-2000

Macula Society, Secretary, 2000-2002


3

Macula Society, President-elect, 2002-2004

Macula Society, President 2004-2006

Sub-section Editorial Consultant, Medical Ethics

Archives of Ophthalmology, 1992-1994

Data and Safety Monitoring Board, Silicone Study

Multi-Center Randomized Clinical Trial, 1986

Retinal Disease Committee, National Society to Prevent

Blindness, 1986

Publication Review Board, Early Treatment Diabetic Study

Multi-Center Randomized Clinical Trial, 1986-1991

Member - Task Force on Alternative Therapies

American Academy of Ophthalmology, Jan. 1, 2000

Johns Hopkins Positions:

Joint Committee on Clinical Investigation (IRB) 1986-2001

Medical Ethics Committee, 1987 through 1998

Chairman, Medical Ethics Committee, 1997 through 1998

Editor, Medical Ethics Newsletter, 1991 through 1998

Palliative Care Steering Committee, 1998

Laser Committee, 1985

Medical Committee for Performing Artists, 1987

Clinical Research Center Committee

Wilmer Positions:

Review of all human research projects for JCCI (IRB), 1986-2001

Wilmer Library Committee, 1975-1990

Wilmer Memorial Committee


4

Grants:

Principal Investigator:

Bioethics, Patient-Physician Trust Relationship, 2002-2003

Bioethics, Progressive Vision Loss, 2002

Diabetes Research and Wellness Foundation

Grant for Diabetic Retinopathy Screening, 1994-present

HSCRC Grant for Diabetic Retinopathy Screening, 1993-1996

Central Vein Occlusion Study, Participating Center, NEI, 1988-1994

Multi-Center BVOS: Macular Edema Data Analysis, NEI

EY06142, 1986-1989

Branch Vein Occlusion Study, Coordinating Center, NEI, EY02466

National Director of Multi-University Clinical Trial, 1976-1986

Branch Vein Occlusion Study, Participating Center, NEI, EY02469,

1976-1986

Studies in Retinitis Pigmentosa, NEI, EY01791, 1976-1994

Retinitis Pigmentosa

Retinitis Pigmentosa Foundation, 1977-1980

Experimental Retinal Neovascularization, NEI, EY01368, 1975-1978

Consultant:

Early Treatment Diabetic Retinopathy Study

Juvenile Diabetic Retinopathy Study

Studies of Visual Function in Retinal Ischemia

Retinal Function Changes Accompanying Age-Related Drusen

Blindness and Visual Impairment Among Mexican Hispanics

Program Coordinator:

Wilmer Core Grant, NEI, EY01765


5

Publications:

1. Finkelstein, D, Grusser, OJ. Frog retina: Detection of movement. Science, 1965; 1050-1053.

2. Finkelstein, D, Grusser, OJ, Reich-Motel, H. Reaktionen einzelner retinaneurone des frosches

(rana esculenta) auf bewegte reize verschiedener winkelgeschwindigkeit. Pflugers Archiv fur die

gesamte. Physiologie, 1965; (283): R48-49.

3. Grusser, OJ, Finkelstein, D. Analyses eines auf “bewegungswahrnehmung:” spezialisierten

neuronensytems in der froschnetzhut. In der Kybernetik: R. Oldenbourg, Verlag, Munchen Wien,

1967.

4. Grusser, OJ, Grusser-Cornehls, U, Finkelstein, D, Henn, V, Patutschnik, M, Butenandt, E. A

quantitative analysis of movement detecting neurons of the frog’s retina. Pflugers Archiv fur die

gesamte Physiologie, 1967; (293): 100-106.

5. Finkelstein, D, Gouras, P, Hoff, M. Human electroretinogram near the absolute threshold of

vision. Invest Ophthalmol Vis Sci., 1968; (7): 214-218.

6. Grusser, OJ, Finkelstein, D, Grusser-Cornehls, U. The effect of stimulus velocity on the response

of movement sensitive neurons of the frog’s retina. Pflugers Archiv. 1968; (300): 49-66.

7. Finkelstein, D, Gouras, P. Visual electrophysiology: an introduction to ERG, EOG, ERP, and

VER. Int Ophthalmol Clin., 1969; 9(4): 857-881.

8. Finkelstein, D, Gouras, P. Human electroretinogram near the absolute threshold of vision. Int

Ophthalmol Clin., 1969; 9(4): 1073-1081.

9. Einaguler, RB, Finkelstein, D, Gunkel, RD, Brown, CH, Collins, EA. Retinitis pigmentosa and

lymphocytic leukemia. Arch Ophthalmol., 1971; (85): 699-702.

10. Diabetic Retinopathy Study Research Group: Preliminary report on the effects of

photocoagulation therapy. Am J Ophthalmol., 1976; (81): 383-396.

11. Brem, S, Brem, H, Folkman, J, Finkelstein, D, Patz, A. Prolonged tumor dormancy by

prevention of neovascularization in the vitreous. Cancer Res., 1976; (36): 2807-2812.

12. Fine, S, Patz, A, Orth, D, Klein, M, Finkelstein, D, Yassur, Y. Subretinal neovascularization

developing after prophylactic argon laser photocoagulation of atrophic “histo spots.” Am J

Ophthalmol., 1976; (82): 352-357.

13. Radius, R, Finkelstein, D. Central retinal artery occlusion (reversible) in sickle trait with

glaucoma. Br J Ophthalmol., 1976; (60): 428-430.


6

14. Charache, S, Finkelstein, D, Lietman, P, Scott, J. Peripheral and optic neuritis in a patient with

hemoglobin SC disease during treatment of salmonella osteomyelitis with chloramphenicol. The

Johns Hopkins Medical Journal, 1977; (140): 121-124.

15. Finkelstein, D, Brem, S, Patz, A, Folkman, J, Miller, S, Chen, C. Experimental retinal

neovascularization induced by intravitreal tumors. Am J Ophthalmol., 1977; (83): 660-664.

16. Patz, A, Fine, S, Finkelstein, D, Yassur, Y. Diseases of the macula: diagnosis and management

of choroidal neovascularization. Trans Am Acad Ophthalmol & Otolaryngol., 1977; (83): 468-

472.

17. Patz, A, Yassur, Y, Fine, S, Finkelstein, D, Orth, D. Branch retinal venous occlusion. Trans Am

Acad Ophthalmol & Otolaryngol., 1977; (83): 373-378.

18. Finkelstein, D. Macular edema. Int Ophthalmol Clin., 1977; (17): 113-120.

19. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative

diabetic retinopathy: the second report of diabetic retinopathy study findings. Trans Am Acad

Ophthalmol & Otolaryngol., 1978; (85): 82-106.

20. Patz, A, Brem, S, Finkelstein, D, Chen, CH, Lutty, G, Bennett, A, Coughlin, WR, Gardner, J. A

new approach to the problem of retinal neovascularization. Trans Am Acad Ophthalmol &

Otolaryngol., 1978; (85): 626-637.

21. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in

diabetic retinopathy: the third report from the diabetic retinopathy study. Arch Ophthalmol.,

1979; (97): 654-655.

22. Massof, RW, Finkelstein, D, Starr, S, Kenyon, KR, Fleischman, FA, Maumenee, IH. Bilateral

symmetry of vision disorders in typical retinitis pigmentosa. Brit J Ophthalmol., 1979; (63): 90-

96.

23. Massof, RW, Finkelstein, D. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.

Invest Ophthalmol & Vis Sci., 1979; (18): 263-272.

24. Massof, RW, Finkelstein, D. Vision threshold profiles in x-linked retinitis pigmentosa. Invest

Ophthalmol & Vis Sci., 1979; (18): 426-429.

25. Massof, RW, Finkelstein, D. Vision threshold profiles in sector retinitis pigmentosa. Arch

Ophthalmol., 1979; (97): 1899-1904.

26. Report of the National Advisory Eye Council. Vision research: a national plan. 1978-1982.

HEW Publ. 78-1258.


7

27. National Diabetes Advisory Board. Report of national conference on diabetes: current status and

future directions. Appendix to the third Annual Report of the National Diabetes Advisory Board,

NIH publ. 1980; 80-2073.

28. Finkelstein, D. Diabetic retinopathy. Postgraduate Course in Internal Medicine. The Johns

Hopkins School of Medicine, 1980: vol. VI, Program 6:17.

29. Massof, RW, Finkelstein, D. Subclassification of retinitis pigmentosa from two color scotopic

static perimetry. Documenta Ophthalmologica Proceedings Series, Greve, E.L. and Verriest, G.,

eds., 1981: (26): 219-225.

30. Finkelstein, D, Patz, A, Fine, SL, Rice, TA, Murphy, RP. Diabetic foveal abortive retinal

neovascularization. Retina, 1981; (1): 62-66.

31. Massof, RW, Johnson, MA, Finkelstein, D. Peripheral absolute threshold spectral sensitivity in

retinitis pigmentosa. Brit J Ophthalmol., 1981; (65): 112-121.

32. Engerman, R, Finkelstein, D, Aguirre, G, Diddie, KR, Fox, RR, Frank, RN, Varma, SD. Ocular

complications. Diabetes, 1982; (31): 82-88.

33. Massof, RW, Finkelstein, D. Two forms of autosomal dominant primary retinitis pigmentosa.

Documenta Ophthalmologica, 1981; (51): 289-346.

34. Frangieh, GT, Green, WR, Barraquer-Somers, E, Finkelstein, D. Histopathologic study of nine

branch retinal vein occlusions. Arch Ophthalmol., 1982; (100): 1132-1140.

35. Finkelstein, D, Reissig, M, Kashima, H, Massof, R, Hillis, A, Proctor, A. Nasal cilia in retinitis

pigmentosa. Birth Defects: Original article series, 1982; (18): 197-206.

36. Massof, R, Finkelstein, D, Boughman, J. Genetic analysis of subgroups within simplex and

multiplex retinitis pigmentosa. Birth Defects: Original article series, 1982: (18): 161-166.

37. Sternberg, P, Knox, D, Finkelstein, D, Green, RW, Murphy, RP, Patz, A. Acute retinal necrosis

syndrome. Retina, 1982; (2): 145-151.

38. Finkelstein, D, Clarkson, J, Diddie, K, Hillis, A, Kimball, A, Orth, D, Trempe, C. Branch Vein

Occlusion Study Group: Branch vein occlusion: retinal neovascularization outside the involved

segment. Ophthalmology, 1982; (89): 1357-1361.

39. Sternberg, P, Fitzke, F, Finkelstein, D. Cyclic macular edema. Am J Ophthalmol., 1982; (94):

664-669.

40. DeBustros, S, Miller, NR, Finkelstein, D, Massof, R. Bilateral astrocytic hamartomas of the

optic nerve head in retinitis pigmentosa. Retina, 1983; (3): 21-23.


8

41. Branch Vein Occlusion Study Group: Branch vein occlusion study. Ophthalmic Forum. 1983;

(1): 56.

42. Cohen, SMZ, Fine, SL, Murphy, RP, Finkelstein, D, Patz, A. Transient delay in segmental

choroidal filling after krypton red laser photocoagulation for choroidal neovascular membranes.

Retina, 1983: (3): 284-290.

43. Massof, RW, Wu, L, Finkelstein, D, Perry, C, Starr, SJ, Johnson, MA. Properties of

electroretinographic intensity response functions in retinitis pigmentosa. Documenta

Ophthalmologica, 1984; (57): 279-296.

44. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in

branch vein occlusion. Am J Ophthalmol., 1984; (98): 271-282.

45. Fine, SL, Murphy, RP, Finkelstein, D, Patz, A. Membership Benefit Module 1: Age-related

macular degeneration. Am Acad Ophthalmol. Focal Points, Clinical Modules for

Ophthalmologists, 1984.

46. Finkelstein, D. The management of macular degeneration in the aging eye. Sightsaving

(National Society to Prevent Blindness), 1984-85; 53(4): 8-9.

47. Sunness, JS, Massof, RW, Johnson, MA, Finkelstein, D, Fine, SL. Peripheral retinal function in

age-related macular degeneration. Arch Ophthalmol., 1985; (103): 811-816.

48. Lang, GK, Surer, JL, Green, WR, Finkelstein, D, Michels, RG, Maumenee, AE. Ocular

reticulum cell sarcoma: clinicopathologic correlation of a case with multifocal lesions. Retina,

1985; (5): 79-86.

49. Little, HL. Nonproliferative diabetic retinopathy. Am Acad Ophthalmol., 1985; Vol. III, Module

11: 1-11. Finkelstein, D; consultant.

50. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of

neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical

trial. Arch Ophthalmol., 1986; (104): 34-41.

51. Massof, RW, Johnson, MA, Sunness, JS, Perry, C, Finkelstein, D. Flicker electroretinogram in

retinitis pigmentosa. Document Ophthalmol., 1986; (61): 231-245.

52. Finkelstein, D. Argon laser photocoagulation for macular edema in branch vein occlusion.

Ophthalmology, 1986; (93): 975-977.

53. El Baba, F, Green, WR, Fleischman, J, Finkelstein, D, De la Cruz, CZ. Clinicopathologic

correlation of lipidization and detachment of the retinal pigment epithelium. Am J Ophthalmol.,

1986; (101): 576-583.


9

54. Patz, A, Finkelstein, D, Fine, ST, Murphy, RP. The role of fluorescein angiography in national

collaborative studies. Ophthalmology, 1986; (93): 1466-1470.

55. Finkelstein, D, Patz, A. Changes in the retinal pigment epithelium associated with cystoid

macular edema. Trans Am Ophthalmol Soc., 1986, (84): 293-303.

56. Finkelstein, D. Current techniques: Branch retinal vein occlusion. Ophthalmology Laser

Therapy, 1987; (2): 121.

57. Bowers, DK, Finkelstein, D, Wolff, SM, Green, WR. Branch retinal vein occlusion: A

clinicopathologic case report. Retina, 1987; (7): 252-259.

58. Finkelstein, D, Clarkson, J, and the Branch Vein Occlusion Study Group. Branch and central

retinal vein occlusions. Focal Points, 1987; Vol. V, Module 12.

59. Wilson, DJ, Finkelstein, D, Quigley, HA, Green, WR. Macular grid photocoagulation: An

experimental study on the primate retina. Arch Ophthalmol., 1988; (106): 100-105.

60. Finkelstein, D. The treatment of BVO: Who, how and why? Video J Ophthalmol., 1988; April,

Vol. IV, #2.

61. Finkelstein, D, Patz, A. Distant effect of peripheral branch vein occlusion on the macula. Trans

Am Ophthalmol Soc, 1988; Vol. LXXXVI: 380-388.

62. Finkelstein, D. Central retinal vein occlusion: The state of the art. Video J Ophthalmol., 1989;

April, Vol. V, #2.

63. Klein, ML, Finkelstein, D. Macular grid photocoagulation for macular edema in central retinal

vein occlusion. Arch Ophthalmol., 1989; (107): 1297-1302.

64. Madreperla, SA, Palmer, RW, Massof, RW, Finkelstein, D. Visual acuity loss in retinitis

pigmentosa: A relationship to the visual field. Arch Ophthalmol., 1990: (108): 358-361.

65. Finkelstein, D. Laser treatment of branch and central retinal vein occlusions. Int Ophthalmol

Clinics, 1990; Spring, Vol. 30, No. 2.

66. Bressler, N, Finkelstein, D, Sunness, J, Maguire, A, Yarian, D. Retinal pigment epithelial tears

through the fovea with preservation of good visual acuity. Arch Ophthalmol., 1990; (108): 1694-

1697.

67. Massof, RW, Dagnelie, G, Benzschawel, T, Palmer, RW, Finkelstein, D. First order

dynamics of visual field loss in retinitis pigmentosa. Clin Vis Sci, 1990; (5): 1-26.


10

68. Finkelstein, D, Feinberg, SJ, Flom, RE, Hedstrom, NJ, Leinhaas, M, Raasch, TW, Rubin, GS,

Massof, RW. Visual prostheses and visual rehabilitation in low vision research, assessment and

management. Curr Opinion in Ophthalmol., 2: 729-732, 1991.

69. Finkelstein, D. Ischemic macular edema: Recognition and favorable natural history in branch

vein occlusion. Arch Ophthalmol., 1992; (110): 1427-1434.

70. Holroyd, S, Rabins, PV, Finkelstein, D, Nicholson, MC, Chase, GA, Wisniewski, SC. Visual

hallucinations in patients with macular degeneration. Amer J Psychiatry, 1992; (149):12.

71. Finkelstein, D, Smith, MK, Faden, R. Informed consent and medical ethics. Arch Ophthalmol.,

1993; (111): 324-326.

72. Central Vein Occlusion Study Group. Baseline and early natural history report. The Central

vein occlusion study. Arch. Ophthalmol., 1993; (111): 1087-1095.

73. The Krypton Argon Regression Neovascularization Study Research Group. Randomized

comparison of Krypton versus argon scatter photocoagulation for diabetic disc

neovascularization. Ophthalmol., 1993; (100): 1655-1664.

74. Finkelstein, D. Laser treatment of macular edema resulting from branch vein occlusion.

Seminars in Ophthalmol., 1994; (9): 23-28.

75. Finkelstein, D. Laser management of branch and central retinal vein occlusion. Chapter 8,

Current Techniques in Ophthalmic Laser Surgery, Curr Med., 1994; 86-91.

76. Holroyd, S, Rabins, PV, Finkelstein, D, Lavrisha, M. Visual hallucinations in patients from an

Ophthalmology clinic and medical clinic population. J Nerv & Mental Dis., 1994; (182): 273-

276.

77. The Central Vein Occlusion Study Group M Report. Evaluation of grid pattern photocoagulation

for macular edema in central vein occlusion. Ophthalmology, 1995: (102): 1425-1433.

78. The Central Vein Occlusion Study Group N Report. A randomized clinical trial of early

panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology, 1995; (102):

1434-1444.

79. Kempster, RC, Green, WR, Finkelstein, D. Choroidal rupture - Clinicopathologic correlation of

an unusual case. Retina, 1996; (160): 57-63.

80. Dunn, JP, Noorily, SW, Petri, M, Finkelstein, D, Rosenbaum, JT, Jabs, DA. Antiphospholipid

antibodies and retinal vascular disease. Lupus, 1996; (5): 313-322.


11

81. Finkelstein, D. Laser therapy for central retinal vein obstruction. Curr Opinion in Ophthalmol.,

1996; (7): 80-83.

82. The Central Vein Occlusion Study Group. Natural history and clinical management of central

retinal vein occlusion. Arch Ophthalmol., 1997; (115):486-491.

83. Finkelstein, D, Clarkson, JG, Hillis, A. Branch and central vein occlusion. Focal Points. Am

Acad Ophthalmol., 1997; Vol. XV, 1-13.

84. Fekrat, S, Finkelstein, D. Current concepts in the management of central retinal vein occlusion.

Curr Opinion in Ophthalmol., 8;111: 50-54, 1997.

85. Finkelstein, D, Wu, AW, Holtzman, NA, Smith, ME. When a physician harms a patient by a

medical error: Ethical, legal, and risk-management considerations. The J of Clin Ethics, 1997;

(8): 330-335.

86. Fekrat, S, Goldberg, MF, Finkelstein, D. Laser-induced chorioretinal venous anastomosis for

perfused central retinal vein occlusion. Wilmer Retina Update, 1997; 3(2): 23-27.

87. Fekrat, S, Goldberg, MF, Finkelstein, D. Laser-induced chorioretinal venous anastomosis for

nonischemic central or branch retinal vein occlusion. Arch Ophthalmol., 1998; (116): 43-52.

88. Agard, E, Finkelstein, D, Wallach, E. Cultural diversity and informed consent. The J Clin

Ethics, 1998; (9): 173-176,.

89. Fekrat, S, Goldberg, MF, Finkelstein, D. Anastomosis venosa coriorretiniana inducida por laser

para la oclusion venosa central o de rama no isquemica. Arch Ophthalmol., (Edicion Espanola)

1998; (9): 127-137.

90. Cooney, MJ, Fekrat, S, Finkelstein, D. Current concepts in the management of central retinal

vein occlusion. Curr Opinion in Ophthalmol., 1998; (9): 47-50.

91. Duh, EJ, Finkelstein, D, Schneider, T, Malouf, A, Kaplan, G. Bilateral iris

neovascularization as the initial sign of obesity-hypoventilation (Pickwickian) syndrome:

Hypoxia/hypercapnia as a stimulus for angiogenesis. Arch Ophthalmol., 2000; (118): 1298-

1300.

92. Finkelstein, D. The utility of ranking Ophthalmology centers. The ranking of Ophthalmology

centers in Ophthalmology and lay publications is not appropriate for medicine in today’s

business world. Arch Ophthalmol., 2000; (118): 1579-1580.

93. Hayeems, RZ, Geller, G, Finkelstein, D, Faden, RR. How patients experience progressive loss of

visual function: A model of adjustment. Brit J Ophthalmol., 2005; (89):615-620.

94. Chang, M, and Finkelstein, D. Modified laser-induced chorioretinal anastomosis for treatment

of long-standing perfused central retinal vein occlusion (CRVO). Retina. September 2006; 26(7):

824-825.

95. The PKC-DRS Study Group*. The effect of ruboxistaurin on visual loss in patients with

moderately severe to very severe nonproliferative diabetic retinopathy. Diabetes, 2005; (54):

2188-2197.


12

96. The PKC-DMES Study Group*. Effect of ruboxistaurin in patients with diabetic macular edema.

Arch Ophthalmol., 2007; (125): 318-324.

97. Committee for the Diabetic Retinopathy Clinical Research Network. Comparison of the

modified early treatment diabetic retinopathy study and mild macular grid laser

photocoagulation strategies for diabetic macular edema. Arch Ophthalmol., 2007; (125):

469-480.

98. Magyar-Russell G, Fosarelli P, Taylor H, Finkelstein D. Ophthalmology patients’

religious and spiritual beliefs: an opportunity to build trust in the patient-physician

relationship. Arch Ophthalmol. 2008; 126(9):1262-1265.

99. Finkelstein D. Blind faith. Narrative Inquiry in Bioethics, winter 2014; Vol. 4, No. 3, 199-200.


13

Book Chapters:

1. Patz, A, Finkelstein, D, Payne, J. Fluorescein angiography in retrolental fibroplasia. In:

(Documenta Ophthalmology. Proceedings Series: 9). The Hague, Dr. W Junk bv Publishers,

1976; (9): 599-604.

2. Finkelstein, D, Patz, A. Experimental retinal neovascularization. In: The Blood-Retinal

Barriers. JG Cunha-Vaz (ed.), New York and London.

3. Finkelstein, D, Reissig, M, Kashima, H, Massof, RW, Hillis, A, Proctor, A. Ultrastructural

abnormalities in nasal cilia of retinitis pigmentosa patients. In: Genetic Eye Diseases. E Cottie,

I Maumenee, and E Berman (eds.), Alan R Liss, 1982; 197-205.

4. Finkelstein, D, Patz, A, Fine, SL, Rice, TA. Retinal branch vein occlusion study. In:

Management of Retinal Vascular and Macular Disorders. SL Fine and SLOwens (eds.),

Baltimore, Williams and Wilkins, 1983; 1-4.

5. Finkelstein, D, Massof, RW. Status of the Wilmer Institute Retinitis Pigmentosa Center. In:

Management of Retinal Vascular and Macular Disorders. SL Fine and SL Owens (eds.),

Baltimore, Williams and Wilkins, 1983; 73-77.

6. Massof, RW, Finkelstein, D. A two stage hypothesis for the natural course of retinitis

pigmentosa. In: Research in Retinitis Pigmentosa. E Zrenner, H Kastel, HH Goebels (eds.),

Adv Biosci., 1987; (62): 29-58.

7. Finkelstein, D. Ushers syndrome. In: Medical Diagnosis in Ushers Syndrome. Charles C

Thomas, 1988.

8. Finkelstein, D. Branch vein occlusion. In: Medical Retina, Vol. II, chapter 75. Ryan et al.

(eds.), Mosby, 1988; 427-432.

9. Duncan, E, Prickett, HT, Finkelstein, D, McCay, V, Hollingsworth, T. Usher’s syndrome. What

it is, how to cope, and how to help. Charles C Thomas, 1988.

10. Finkelstein, D. Retinal branch vein occlusion. In: Laser Photocoagulation of the Macula. LA

Yannuzzi (ed.), 1989; 83-89.

11. Finkelstein, D. Branch and central retinal vein occlusion. In: Practical Atlas of Retinal Disease

and Therapy. WR Freeman (ed.), Raven Press, New York, 1993.

12. Fekrat, S, Finkelstein, D. The central vein occlusion study (CVOS). In: Clinical Trials in

Ophthalmologyogy: A Summary and Practice Guide, chapter 8. PJ Kertes and MD Conway

(eds.), Williams and Wilkins, 1998; 129-144.


14

13. Zegarra, H, Finkelstein, D, Singerman, LJ, Niffenegger, JH, Prendergast, SD. Laser management

of branch and central retinal vein occlusions. In: Current Techniques in Ophthalmic Laser

Surgery, 3rd ed. LJ Singerman and G Coscas (eds.), Butterworth Heinemann, 1999; 67-76.

14. Finkelstein, D. Branch retinal vein occlusion. In: Retina-Vitreous-Macula, chapter 25. DR

Guyer, LA Yannuzzi, S Chang, JA Shields, WR Green (eds.), WB Saunders, 1999; 308.

15. Fekrat, S, Finkelstein, D. Venous occlusive disease. In: Vitreoretinal Disease: The Essentials,

chapter 9. CD Regillo, GC Brown, HW Flynn, Jr. (eds.), Thieme Medical Pub., 1999; 117-132.

16. Fekrat, S, Finkelstein, D. Branch retinal vein occlusion. In: Retina. SJ Ryan, R Murphy and AP

Schachat (eds.), Third edition, Mosby, St. Louis, 2001.


15

Letters To The Editor:

1. Branch Vein Occlusion Study Group: Letter to the Editor. Branch vein occlusion study. Invest

Ophthalmol & Vis Sci., 1979; (18): 1097.

2. Branch Vein Occlusion Study Group: Letter to the Editor. Argon laser photocoagulation for

macular edema in branch vein occlusion. Am J Ophthalmol., 1985; (99): 219.

3. Sunness, JS, Massof, RW, Johnson, MA, Finkelstein, D, Fine, SL. Letter to the Editor.

Peripheral retinal function in age-related macular degeneration. Arch Ophthalmol., 1985; (103):

1631.

4. Finkelstein, D, Kimball, A. Letter to the Editor. Rick factors of branch vein occlusion. Arch

Ophthalmol., 1986; (104): 795.

5. Finkelstein, D, Clarkson, J, Goldberg, I, Kimball, A, Orth, D, Ryan, S, Trempe, C: Letter to the

Editor. More information needed regarding neovascularization and vitreous hemorrhage in

branch vein occlusion. Arch Ophthalmol., 1987; (105): 311-312.

6. Finkelstein, D. Letter to the Editor. Defense of Animal Research. Am J Ophthalmol., 1991;

(112): 101.

7. Madreperla, S, Palmer, R, Massof, R, Finkelstein, D. Letter to the Editor. Visual acuity and field

loss in retinitis pigmentosa. Arch Ophthalmol., 1991; (109): 109.

8. Massof, RW, Finkelstein, D. Letter to the Editor. Vitamin A supplementation for retinitis

pigmentosa. Arch Ophthalmol., 1993; (111): 1458-1459.

9. Fekrat, S, Goldberg, MF, Finkelstein, D. Letter to the Editor. Laser-induced chorioretinal

anastomosis and central retinal vein occlusion. Arch Ophthalmol., 1999; (117): 140.


16

Editorials:

1. Finkelstein, D, Massof, RW. Editorial. Louise L. Sloan: Pioneer in clinical vision research.

Arch Ophthalmol., 1982; (100): 1347.

2. Finkelstein, D. Editorial. Oh, the times! Tabloids and other non-peer-reviewed publications.

Arch Ophthalmol., 1985; (103): 1641-1642.

3. Massof, RW, Finkelstein, D. Editorial. Supplemental vitamin A retards loss of ERG amplitude

in retinitis pigmentosa. Arch Ophthalmol., 1993; (111): 751-754.

4. Finkelstein, D, Clarkson, JG. Editorial. Retinal vessel bypass: A promising new clinical

investigative procedure. Arch Ophthalmol., 1995; (113): 421-422.

5. Finkelstein, D, Clarkson, JG. Editorial. Puenteo de los vasos retinianos. Un procedimiento

clinico investigativo nuevo y prometedor. Arch Ophthalmol., (ED.ESP)., 1995; (6): 281-282.


17

Abstracts:

1. Brem, S, Finkelstein, D, Chen, C, Brem, H, Folkman, J, Patz, A. Retinal neovascularization:

experimental induction by intravitreal tumor. Invest Ophthalmol & Vis Sci., Suppl., 1975;

2. Finkelstein, D, Brem, S, Chen, C, Folkman, J, Patz, A. Retinal neovascularization: effect of

intravitreal tumors on retinal vessels. Invest Ophthalmol & Vis Sci., Suppl., 1976.

3. Finkelstein, D, Patz, A, Folkman, J, Kingsley, R, Miller, S, Sternberg, P. Experimental retinal

neovascularization. Invest Ophthalmol & Vis Sci., Suppl., 1977.

4. Massof, RW, Finkelstein, D, Fleischman, J, Maumenee, IH, Kenyon, KR. Foveal vision

abnormalities in retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1977.

5. Clarkson, J, Diddie, K, Finkelstein, D, Orth, D, Trempe, C. Branch vein occlusion: the

development of a multi-center randomized clinical trial. Invest Ophthalmol & Vis Sci., Suppl.,

1978.

6. Massof, RW, Finkelstein, D. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.

Invest Ophthalmol & Vis Sci., Suppl., 1978.

7. Finkelstein, D, Patz, A, Fine, SL. Branch vein occlusion: development of neovascularization.

Invest Ophthalmol & Vis Sci., Suppl., 1979.

8. Massof, RW, Finkelstein, D, Starr, SJ, Fitzke, FW. Subcategories of primary retinitis

pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1979.

9. Palmer, RW, Massof, RW, Finkelstein, D. Heterogeneity within subgroups of retinitis

pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1980.

10. Massof, RW, Fitzke, FW, Finkelstein, D. Foveal temporal resolution in retinitis pigmentosa.

Invest Ophthalmol, & Vis Sci., Suppl., 1980.

11. Johnson, MA, Massof, RW, Finkelstein, D. Peripheral absolute threshold spectral sensitivity in

retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1980.

12. Reissig, M, Finkelstein, D, Kashima, H, Massof, RW, Hillis, A, Proctor, D. Nasal cilia in

retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1981; (20): 41.

13. Massof, RW, Wu, L, Finkelstein, D, Perry, C, Starr, SJ, Fitzke, FW, Johnson, MA. Properties of

the electroretinogram in retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1981; (20):

121.


18

14. Sternberg, P, Fitzke, FW, Finkelstein, D. Cyclic macular edema. Invest Ophthalmol & Vis Sci.,

Suppl., 1982; (22): 8.

15. Massof, RW, Finkelstein, D. A possible non-genetic form of retinitis pigmentosa. Invest

Ophthalmol & Vis Sci., Suppl., 1982; (22): 138.

16. Finkelstein, D, Diddie, K, Hillis, A, Kimball, A, Orth, D, Trempe, C, Clarkson, J. Branch vein

occlusion: neovascularization outside the involved segment. Invest Ophthalmol & Vis Sci., Suppl.,

1982; (22): 195.

17. Lindsey, P, Finkelstein, D, D’Anna, S. Experimental foveal relocation. Invest Ophthalmol &Vis

Sci., Suppl., 1983; (24): 242.

18. Massof, RW, Benzschawel, T, Palmer, R, Finkelstein, D. Natural course of visual sensitivity loss

in simplex and multiplex retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1983; (24):

292.

19. Johnson, MA, Finkelstein, D, Massof, RW. Retinal function in branch vein occlusion. Invest


20. The Branch Vein Occlusion Study Group: “Progressing” branch vein occlusion. Invest


21. Patel, A, Michels, RG, Finkelstein, D. BVO neovascularization: status following vitrectomy.

Invest Ophthalmol & Vis Sci., Suppl., 1984; (25): 252.

22. Massof, RW, Benzschawel, T, Emmel, T, Palmer, R, Finkelstein, D. The spread of retinal

degeneration in retinitis pigmentosa. Invest Ophthalmol & Vis Sci., Suppl., 1984: (25): 196.

23. Stevens, RA, Finkelstein, D. Retinal pigment epithelial removal; an experimental model. Invest


24. Sunness, JS, Massof, RW, Johnson, MA, Finkelstein, D, Fine, SL. Age-related macular

degeneration and peripheral retinal function. Invest Ophthalmol & Vis Sci., Suppl., 1985; (26):

58.

25. Massof, RW, Sunness, JS, Palmer, R, Emmel, T, Finkelstein, D. Unilateral and asymmetric

retinitis pigmentosa: characteristics and natural history. Invest Ophthalmol & Vis Sci., Suppl.,

1985; (26): 128.

26. Johnson, MA, Finkelstein, D. The electroretinogram in retinal vein occlusion. Invest


27. Johnson, MA, Finkelstein, D. Neovascularization and retinal sensitivity loss in patients with

retinal ischemia. Invest Ophthalmol & Vis Sci., Suppl., 1986; (27): 145.


19

28. Finkelstein, D, Patz, A. Presumed RPE change secondary to cystoid macular edema. Invest


29. El Baba, F, Green , WE, Fleischmann, J, Finkelstein, D, De la Cruz, ZC. Lipidization and

detachment of the RPE. Invest Ophthalmol & Vis Sci., Suppl., 1986: (27): 319.

30. Choy, D, Massof, R, Finkelstein, D. Normal visual fields in retinitis pigmentosa. Invest


31. McPhee, T, Johnson, M, Massof, RW, Finkelstein,D. ERG after fundus photography and

fluorescein angiography. Invest Ophthalmol & Vis Sci., Suppl., 1987; (28): 236.

32. Wilson, DJ, Finkelstein, D, Quigley, HA, Green, WR. “Grid” macular photocoagulation: A

quantitative histologic study of the effect on the primate retinal capillaries. Invest Ophthalmol &

Vis Sci., Suppl., 1987; (28): 320.

33. Finkelstein, D, Massof, RW, Palmer, RW. Retinitis pigmentosa: Design of a pilot laser clinical

trial in progress. Invest Ophthalmol & Vis Sci., Suppl., 1988; (29): 142.

34. Finkelstein, D, Bressler, N, Sunness, J, Yarrian, D. Good visual acuity following pigment

epithelial rip through the fovea. Invest Ophthalmol & Vis Sci., Suppl., 1990; (31): 48.

35. Madreperla, S, Palmer, R, Massof, R, Finkelstein, D. Visual acuity in retinitis pigmentosa.


36. Finkelstein, D. Ischemic macular edema. Invest Ophthalmol & Vis Sci., Suppl., 1992; (33): 805.

37. Schneider, TL, Finkelstein, D, Malouf, A, Kaplan, G. Bilateral rubeosis iridis in a 36 year-old

male as the presenting sign of obesity-hypoventilation syndrome: implication for angiogenesis.


38. Dagnelie, G, Sunness, J, Palmer, RW, Finkelstein, D, Massof, RW. Unilateral and asymmetric

retinitis pigmentosa: incidence and long-term follow-up. Invest Ophthalmol & Vis Sci., Suppl.,

1993; (34): 1368.

39. Finkelstein, D, for the Central Vein Occlusion Study Group. Central vein occlusion study:

Design, baseline, and early natural history. Invest. Ophthalmology. & Vis. Sci., Suppl., 1993;

(34): 1442.

40. Zeimer, R, Asrani, S, Zou, S, Goldberg, M, Finkelstein, D, Quigley, H, D’Anna, S. The

retinamap: A method to evaluate retinal pathology and map the retinal thickness. Invest

Ophthalmol & Vis Sci., Suppl., 1996.


20

41. Zeimer, R, Yang, YS, Vitale, S, Bressler, NM, Finkelstein, D, Schachat, AP, Nishiwaki, H,

Blankenship, Jr., GC. Association between locations of focal laser treatment for clinically

significant macular edema and quantitatively assessed retinal thickening. Invest Ophthalmol &

Vis Sci., Suppl., 1998, 3 (6).

42. Zou, S, Zeimer, R, Yang, YS, Vitale, S, Bressler, NM, Finkelstein, D, Schachat, AP:

Quantitative assessment of reduction in retinal thickening after focal photocoagulation for

clinically significant macular edema. Invest Ophthalmol & Vis Sci., Suppl., 1998.


21

Non-Peer Reviewed:

1. Finkelstein D, Spiritual discussions: Patient values are key. Medical Ethics Advisor, September

2012; 28 (9), 104.

daniel finkelstein, m.d., m.a. curriculum vitae · daniel finkelstein, m.d., m.a. 3 macula society,...

Documents